News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
629,527 Results
Type
Article (52000)
Company Profile (187)
Press Release (577340)
Section
Business (179054)
Career Advice (2706)
Deals (33005)
Drug Delivery (106)
Drug Development (78748)
Employer Resources (163)
FDA (16383)
Job Trends (15180)
News (316045)
Policy (32256)
Tag
Academia (2818)
Alliances (46236)
Alzheimer's disease (1331)
Approvals (16314)
Artificial intelligence (179)
Bankruptcy (333)
Best Places to Work (11544)
Biotechnology (129)
Breast cancer (214)
Cancer (1590)
Cardiovascular disease (138)
Career advice (2276)
CAR-T (117)
Cell therapy (334)
Clinical research (63372)
Collaboration (601)
Compensation (141)
COVID-19 (2787)
C-suite (141)
Data (1472)
Diabetes (201)
Diagnostics (6259)
Earnings (65834)
Employer resources (146)
Events (84391)
Executive appointments (499)
FDA (17167)
Funding (517)
Gene therapy (234)
GLP-1 (712)
Government (4652)
Healthcare (18693)
Infectious disease (2893)
Inflammatory bowel disease (118)
Interviews (505)
IPO (14615)
Job creations (4028)
Job search strategy (1906)
Layoffs (483)
Legal (7306)
Lung cancer (238)
Manufacturing (222)
Medical device (13135)
Medtech (13140)
Mergers & acquisitions (18614)
Metabolic disorders (544)
Neuroscience (1721)
NextGen: Class of 2025 (6753)
Non-profit (4845)
Northern California (1779)
Obesity (311)
Opinion (226)
Patents (126)
People (53710)
Phase I (19675)
Phase II (27684)
Phase III (21228)
Pipeline (625)
Postmarket research (2560)
Preclinical (7630)
Radiopharmaceuticals (224)
Rare diseases (306)
Real estate (5677)
Regulatory (21953)
Research institute (2500)
Resumes & cover letters (414)
Southern California (1592)
Startups (3557)
United States (15299)
Vaccines (674)
Weight loss (234)
Date
Today (112)
Last 7 days (420)
Last 30 days (1910)
Last 365 days (32657)
2025 (1792)
2024 (33083)
2023 (37837)
2022 (48493)
2021 (52902)
2020 (52612)
2019 (46515)
2018 (35737)
2017 (32329)
2016 (31337)
2015 (35415)
2014 (27071)
2013 (22252)
2012 (23986)
2011 (24759)
2010 (22069)
Location
Africa (921)
Arizona (146)
Asia (37536)
Australia (6475)
California (4113)
Canada (1333)
China (345)
Colorado (194)
Connecticut (193)
Europe (86172)
Florida (546)
Georgia (133)
Illinois (408)
Indiana (239)
Maryland (655)
Massachusetts (2766)
Michigan (180)
Minnesota (288)
New Jersey (1050)
New York (1100)
North Carolina (761)
Northern California (1779)
Ohio (141)
Pennsylvania (860)
South America (1280)
Southern California (1592)
Texas (554)
Utah (129)
Washington State (398)
629,527 Results for "selexis sa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
KBI Biopharma and Selexis SA Appoint J.D. Mowery as CEO
KBI Biopharma, Inc. (KBI) and Selexis SA, both JSR Life Sciences companies, today announced the appointment of J.D. Mowery as Chief Executive Officer (CEO).
April 17, 2023
·
3 min read
Deals
JSR Life Sciences Announces Operational Consolidation of KBI Biopharma, Inc. and Selexis SA to Operate as one Organization, Providing Seamless Experience for Partners
JSR Life Sciences today announced that KBI Biopharma, Inc. (KBI) and Selexis SA are consolidating as one organization under the KBI Biopharma name to accelerate innovation and growth for its global biopharma customers.
May 31, 2023
·
4 min read
RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of its annual general meeting (AGM) of shareholders, which took place in Geneva today.
June 27, 2024
·
3 min read
Business
KBI Biopharma, Inc. and Selexis SA Expand Executive Leadership Team with the Appointment of Abdelaziz Toumi, Ph.D. as Chief Business Officer
KBI Biopharma, Inc. (KBI) and Selexis SA (Selexis) today announced that Abdelaziz Toumi, Ph.D., will begin serving as the companies’ Chief Business Officer.
October 31, 2022
·
3 min read
Press Releases
Acquisition of Ovizio Imaging Systems SA
October 17, 2024
·
1 min read
Business
KBI Biopharma SA and Selexis SA Expand in Europe by Opening an Integrated Biologics Manufacturing Facility in Geneva, Switzerland
KBI Biopharma SA and Selexis SA, both JSR Life Sciences companies, announced that an expanded, fully-integrated mammalian contract development and manufacturing services facility is now open and operational in Geneva, Switzerland.
June 14, 2022
·
3 min read
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of the extraordinary general meeting of shareholders, which took place in Geneva , Friday, April 26, 2024.
April 26, 2024
·
4 min read
Deals
Stryker completes acquisition of SERF SAS
Stryker (NYSE: SYK), a leading global medical technology company, announced today that it has completed the previously announced acquisition of SERF SAS, a France -based joint replacement company, from Menix.
March 21, 2024
·
4 min read
Business
ExcellGene SA and Cytovance Biologics Join Forces to Transform Large Molecule Biologics Development and Manufacture
ExcellGene SA proudly announces its strategic collaboration with Cytovance Biologics, a renowned Contract Development and Manufacturing Organization based in the USA.
May 8, 2024
·
3 min read
Press Releases
ChemoMetec makes offer to buy Ovizio Imaging Systems SA
September 23, 2024
·
1 min read
1 of 62,953
Next
